| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 |
U01
|
February 24, 2022 |
July 02, 2022 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 |
UH2/UH3
|
April 05, 2022 |
July 02, 2022 |
| Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 |
Supp
|
May 20, 2022 |
July 06, 2022 |
| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 |
R01
|
March 02, 2022 |
July 09, 2022 |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)- PAR-20-153 |
R25
|
March 30, 2020 |
July 14, 2022 |
| Limited Competition Emergency Awards—Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)- PAR-21-276 |
S10
|
July 16, 2021 |
July 16, 2022 |
| Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-106 |
P30
|
February 03, 2020 |
July 29, 2022 |
| Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-107 |
P30
|
February 03, 2020 |
July 29, 2022 |
| Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)- PAR-20-158 |
R01
|
March 31, 2020 |
July 29, 2022 |
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 |
R01
|
April 05, 2022 |
July 30, 2022 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
| Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 |
UG3/UH3
|
April 13, 2022 |
August 04, 2022 |
| Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 |
U2C
|
June 06, 2022 |
August 11, 2022 |
| International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 |
R01
|
February 04, 2020 |
August 20, 2022 |
| Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 |
U24
|
June 06, 2022 |
August 26, 2022 |
| Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 |
R01
|
October 24, 2019 |
September 08, 2022 |
| NIAID Investigator-Initiated Program Project Applications (P01 Clinical Trial Not Allowed)- PAR-20-072 |
P01
|
December 09, 2019 |
September 08, 2022 |
| HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)- PAR-20-231 |
K01
|
June 16, 2020 |
September 08, 2022 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 |
R01
|
May 12, 2022 |
September 13, 2022 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
| Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 |
U24
|
June 14, 2022 |
September 16, 2022 |
| Limited Competition—Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)- PAR-22-056 |
U42
|
November 03, 2021 |
September 26, 2022 |
| Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)- RFA-DK-21-021 |
R43/R44
|
June 25, 2021 |
October 08, 2022 |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 |
P01
|
May 27, 2022 |
October 14, 2022 |
